{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Is Microbot Medical, Inc. technically bullish or bearish?
As of June 17, 2025, the technical trend is mildly bullish, supported by mixed indicators across various time frames, suggesting a cautious bullish outlook.
Who are in the management team of Microbot Medical, Inc.?
As of March 2022, the management team of Microbot Medical, Inc. is led by Mr. Harel Gadot, who is the Chairman, President, and CEO, alongside independent directors Mr. Yoseph Bornstein, Mr. Scott Burell, Mr. Prattipati Laxminarain, Mr. Martin Madden, and Ms. Aileen Stockburger.
What does Microbot Medical, Inc. do?
Microbot Medical, Inc. is a pre-clinical medical device company specializing in robotic endoluminal surgery devices, with a market cap of USD 88.03 million and a recent net profit of -3 million. The company operates in the Pharmaceuticals & Biotechnology industry and currently does not pay dividends.
How big is Microbot Medical, Inc.?
As of Jun 18, Microbot Medical, Inc. has a market capitalization of 88.03 million, with net sales of 0.00 million and a net profit of -11.66 million over the latest four quarters. Shareholder's funds are 3.53 million, and total assets are 6.03 million as of Dec 24.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
